Chemross Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.35 Cr
as on 24-10-2024
- Revenue 6.57%
(FY 2023)
- Profit 3.80%
(FY 2023)
- Ebitda 44.77%
(FY 2023)
- Net Worth 83.58%
(FY 2023)
- Total Assets 27.63%
(FY 2023)
About Chemross Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹1.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Kumar and Vijay Kumar serve as directors at the Company.
- CIN/LLPIN
U24304CH2019PTC042737
- Company No.
042737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2019
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chemross Lifesciences Private Limited offer?
Chemross Lifesciences Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines, Anti Allergic Drug, Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Chemross Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kumar  | Managing Director | 04-May-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Kumar | Additional Director | 16-Mar-2022 | Current |
Financial Performance of Chemross Lifesciences.
Chemross Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.57% increase. The company also saw a slight improvement in profitability, with a 3.8% increase in profit. The company's net worth Soared by an impressive increase of 83.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemross Lifesciences?
In 2023, Chemross Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Atin Healthcare Private LimitedActive 3 years 7 months
Sanjeev Kumar and Vijay Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Jan 2023 | ₹1.50 Cr | Open |
Others Creation Date: 29 Nov 2021 | ₹1.35 Cr | Satisfied |
How Many Employees Work at Chemross Lifesciences?
Unlock and access historical data on people associated with Chemross Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemross Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemross Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
